Evolutionary Genomics, Inc. (FNAM)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | -0.35 USD | 36.96% |
| 2021 | -0.46 USD | -58.62% |
| 2020 | -0.29 USD | -123.08% |
| 2019 | -0.13 USD | 31.58% |
| 2018 | -0.19 USD | -107.2% |
| 2017 | -0.09 USD | 54.15% |
| 2016 | -0.20 USD | -243.05% |
| 2015 | -0.06 USD | -871.67% |
| 2014 | -0.01 USD | 96.0% |
| 2013 | -0.15 USD | -15.38% |
| 2012 | -0.13 USD | 0.0% |
| 2011 | -0.13 USD | 27.78% |
| 2010 | -0.18 USD | -28.57% |
| 2009 | -0.14 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 100.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q2 | -0.08 USD | 10.21% |
| 2022 Q1 | -0.09 USD | 19.0% |
| 2022 Q4 | -0.04 USD | 53.24% |
| 2022 Q3 | -0.08 USD | -2.38% |
| 2022 FY | - USD | 36.96% |
| 2021 Q2 | -0.09 USD | -7.79% |
| 2021 FY | - USD | -58.62% |
| 2021 Q4 | -0.11 USD | 38.89% |
| 2021 Q3 | -0.18 USD | -91.29% |
| 2021 Q1 | -0.09 USD | 69.9% |
| 2020 Q1 | -0.04 USD | 5.08% |
| 2020 Q2 | -0.05 USD | -21.9% |
| 2020 Q3 | 0.08 USD | 259.68% |
| 2020 Q4 | -0.29 USD | -462.5% |
| 2020 FY | - USD | -123.08% |
| 2019 Q1 | -0.03 USD | -8.25% |
| 2019 Q2 | -0.03 USD | 9.38% |
| 2019 Q3 | -0.03 USD | 13.92% |
| 2019 Q4 | -0.04 USD | -62.78% |
| 2019 FY | - USD | 31.58% |
| 2018 FY | - USD | -107.2% |
| 2018 Q4 | -0.03 USD | 30.16% |
| 2018 Q1 | -0.05 USD | -155.77% |
| 2018 Q2 | -0.06 USD | -23.53% |
| 2018 Q3 | -0.05 USD | 25.94% |
| 2017 FY | - USD | 54.15% |
| 2017 Q4 | 0.09 USD | 305.58% |
| 2017 Q3 | -0.04 USD | 5.49% |
| 2017 Q2 | -0.05 USD | 49.39% |
| 2017 Q1 | -0.09 USD | -95.43% |
| 2016 FY | - USD | -243.05% |
| 2016 Q1 | -0.05 USD | -7.84% |
| 2016 Q2 | -0.05 USD | -9.7% |
| 2016 Q3 | -0.05 USD | 15.1% |
| 2016 Q4 | -0.05 USD | 0.22% |
| 2015 Q1 | -0.00 USD | 96.03% |
| 2015 Q2 | -0.00 USD | 0.0% |
| 2015 Q3 | -0.00 USD | -62.5% |
| 2015 FY | - USD | -871.67% |
| 2015 Q4 | -0.05 USD | -1665.38% |
| 2014 FY | - USD | 96.0% |
| 2014 Q2 | -0.08 USD | -327.96% |
| 2014 Q4 | -0.04 USD | 43.08% |
| 2014 Q1 | -0.02 USD | 30.86% |
| 2014 Q3 | -0.07 USD | 11.06% |
| 2013 Q2 | -0.07 USD | -155.64% |
| 2013 Q1 | -0.03 USD | 9.22% |
| 2013 Q3 | -0.03 USD | 60.15% |
| 2013 Q4 | -0.03 USD | 0.74% |
| 2013 FY | - USD | -15.38% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | -0.03 USD | -20.58% |
| 2012 Q3 | -0.02 USD | -17.96% |
| 2012 Q1 | -0.06 USD | -259.75% |
| 2012 Q2 | -0.02 USD | 63.99% |
| 2011 Q1 | -0.06 USD | 38.64% |
| 2011 Q3 | -0.05 USD | -218.92% |
| 2011 Q2 | -0.01 USD | 73.52% |
| 2011 FY | - USD | 27.78% |
| 2011 Q4 | -0.02 USD | 66.31% |
| 2010 FY | - USD | -28.57% |
| 2010 Q4 | -0.09 USD | -38.03% |
| 2010 Q1 | -0.00 USD | -32.14% |
| 2010 Q3 | -0.07 USD | -211.32% |
| 2010 Q2 | -0.02 USD | -472.97% |
| 2009 Q4 | -0.00 USD | -16.67% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | -0.00 USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| America Great Health | - USD | Infinity% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| Innovation1 Biotech Inc. | -0.70 USD | 50.0% |
| Point of Care Nano-Technology, Inc. | -0.10 USD | -250.0% |
| Vicapsys Life Sciences, Inc. | -0.03 USD | -923.392% |